David Ermert
David Ermert
Researcher at Lund University
Vahvistettu sähköpostiosoite verkkotunnuksessa
Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans
CF Urban, D Ermert, M Schmid, U Abu-Abed, C Goosmann, W Nacken, ...
PLoS pathogens 5 (10), e1000639, 2009
Mouse neutrophil extracellular traps in microbial infections
D Ermert, CF Urban, B Laube, C Goosmann, A Zychlinsky, V Brinkmann
Journal of innate immunity 1 (3), 181-193, 2009
C4b-binding protein: the good, the bad and the deadly. Novel functions of an old friend
D Ermert, AM Blom
Immunology letters 169, 82-92, 2016
Fungal and bacterial killing by neutrophils
D Ermert, A Zychlinsky, C Urban
Host-Pathogen Interactions: Methods and Protocols, 293-312, 2009
Candida albicans escapes from mouse neutrophils
D Ermert, MJ Niemiec, M Röhm, A Glenthøj, N Borregaard, CF Urban
Journal of leukocyte biology 94 (2), 223-236, 2013
Vitamin K–dependent protein S: beyond the protein C pathway
J van der Meer, T van der Poll, C van't Veer, L Suleiman, C Négrier, ...
Seminars in thrombosis and hemostasis 44 (02), 176-184, 2018
Catch me if you can: Streptococcus pyogenes complement evasion strategies
M Laabei, D Ermert
Journal of Innate Immunity 11 (1), 3-12, 2018
Dual transcriptome of the immediate neutrophil and Candida albicans interplay
MJ Niemiec, C Grumaz, D Ermert, C Desel, M Shankar, JP Lopes, IG Mills, ...
BMC genomics 18 (1), 1-21, 2017
Virulence of group A streptococci is enhanced by human complement inhibitors
D Ermert, J Shaughnessy, T Joeris, J Kaplan, CJ Pang, EA Kurt-Jones, ...
PLoS pathogens 11 (7), e1005043, 2015
A family of secreted pathogenesis‐related proteins in Candida albicans
M Röhm, E Lindemann, E Hiller, D Ermert, K Lemuth, D Trkulja, ...
Molecular microbiology 87 (1), 132-151, 2013
Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of …
D Ermert, A Weckel, V Agarwal, IM Frick, L Björck, AM Blom
Journal of Biological Chemistry 288 (45), 32172-32183, 2013
The hijackers guide to escaping complement: Lessons learned from pathogens
D Ermert, S Ram, M Laabei
Molecular immunology 114, 49-61, 2019
The proteasome system in infection: impact of β5 and LMP7 on composition, maturation and quantity of active proteasome complexes
T Joeris, N Schmidt, D Ermert, P Krienke, A Visekruna, U Kuckelkorn, ...
PloS one 7 (6), e39827, 2012
Factor H–IgG chimeric proteins as a therapeutic approach against the Gram-positive bacterial pathogen Streptococcus pyogenes
AM Blom, M Magda, L Kohl, J Shaughnessy, JD Lambris, S Ram, ...
The Journal of Immunology 199 (11), 3828-3839, 2017
Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense
SE Thorslund, D Ermert, A Fahlgren, SF Erttmann, K Nilsson, ...
Infection and immunity 81 (1), 11-22, 2013
Moonlighting of Helicobacter pylori catalase protects against complement-mediated killing by utilising the host molecule vitronectin
C Richter, O Mukherjee, D Ermert, B Singh, YC Su, V Agarwal, AM Blom, ...
Scientific reports 6 (1), 24391, 2016
Human IgG increases virulence of Streptococcus pyogenes through complement evasion
D Ermert, A Weckel, M Magda, M Mörgelin, J Shaughnessy, PA Rice, ...
The Journal of Immunology 200 (10), 3495-3505, 2018
FACIN, a double-edged sword of the emerging periodontal pathogen Filifactor alocis: a metabolic enzyme moonlighting as a complement inhibitor
M Jusko, B Miedziak, D Ermert, M Magda, BC King, E Bielecka, ...
The Journal of Immunology 197 (8), 3245-3259, 2016
C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections
S Bettoni, J Shaughnessy, K Maziarz, D Ermert, S Gulati, B Zheng, ...
JCI insight 4 (23), 2019
Assessment of neutrophil chemotaxis upon G-CSF treatment of healthy stem cell donors and in allogeneic transplant recipients
A Thunström Salzer, MJ Niemiec, A Hosseinzadeh, M Stylianou, F Åström, ...
Frontiers in immunology 9, 1968, 2018
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20